The Research Advocate: May 2020
The May 2020 issue of Research!America’s newsletter, The Research Advocate, is now online! In this issue:
Research!America’s Response to COVID-19: In January 2020, the first case of COVID-19 was reported in Washington state. The days since then have been unprecedented in global history. The medical and research community, including so many of our alliance members, have taken on the incredible challenge of beating back the novel coronavirus, not just on the front lines in hospitals, but in laboratories across the world working to understand the virus to protect public health.
Webinar Explores COVID-19 Vaccines and Treatment: As the COVID-19 pandemic surpasses one million cases in the United States, Research!America brought together experts to discuss the R&D landscape for vaccines and treatments. The webinar was moderated by Research!America board member, former FDA Commissioner Dr. Mark McClellan, Director of the Duke-Margolis Health Policy Center and featured Dr. Stefano Bertuzzi, CEO of the American Society for Microbiology, and former CDC Director Dr. Julie Gerberding, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health at Merck.
Member Spotlight: Global Health Technologies Coalition (GHTC): The Global Health Technologies Coalition’s (GHTC) mission is to advance policies to accelerate the creation of new vaccines, drugs, diagnostics, and other tools to bring healthy lives within reach for all people.
Federal Policy Update: Earlier this week the Senate announced it will reconvene in Washington, D.C. on Monday, May 4, 2020. The House may not return until May 11 at the earliest. It is unclear what legislation the Senate may take up when it returns. Last week, Congress passed a fourth legislative package responding to the COVID-19 pandemic.
17 Initiatives Strengthening the COVID Response: The nationwide and global response to the COVID-19 pandemic is relying on numerous research initiatives around the country to find treatments, vaccines, and more. Here we highlight just some of the many exciting initiatives involving our alliance members.
There’s more! Read the full issue here!